952 related articles for article (PubMed ID: 25900159)
21. A one-year survey of carbapenemase-producing Klebsiella pneumoniae in Italy: beyond the ICU.
Corcione S; Rocchetti A; Argentero PA; Raso R; Zotti CM; De Rosa FG; Ghisetti V
Clin Microbiol Infect; 2015 Feb; 21(2):e11-3. PubMed ID: 25682279
[No Abstract] [Full Text] [Related]
22. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience.
Lübbert C; Faucheux S; Becker-Rux D; Laudi S; Dürrbeck A; Busch T; Gastmeier P; Eckmanns T; Rodloff AC; Kaisers UX
Int J Antimicrob Agents; 2013 Dec; 42(6):565-70. PubMed ID: 24100228
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study.
Giacobbe DR; Del Bono V; Trecarichi EM; De Rosa FG; Giannella M; Bassetti M; Bartoloni A; Losito AR; Corcione S; Bartoletti M; Mantengoli E; Saffioti C; Pagani N; Tedeschi S; Spanu T; Rossolini GM; Marchese A; Ambretti S; Cauda R; Viale P; Viscoli C; Tumbarello M;
Clin Microbiol Infect; 2015 Dec; 21(12):1106.e1-8. PubMed ID: 26278669
[TBL] [Abstract][Full Text] [Related]
24. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study.
Orsi GB; Bencardino A; Vena A; Carattoli A; Venditti C; Falcone M; Giordano A; Venditti M
Infection; 2013 Feb; 41(1):61-7. PubMed ID: 23070604
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae.
Tumbarello M; Trecarichi EM; Corona A; De Rosa FG; Bassetti M; Mussini C; Menichetti F; Viscoli C; Campoli C; Venditti M; De Gasperi A; Mularoni A; Tascini C; Parruti G; Pallotto C; Sica S; Concia E; Cultrera R; De Pascale G; Capone A; Antinori S; Corcione S; Righi E; Losito AR; Digaetano M; Amadori F; Giacobbe DR; Ceccarelli G; Mazza E; Raffaelli F; Spanu T; Cauda R; Viale P
Clin Infect Dis; 2019 Jan; 68(3):355-364. PubMed ID: 29893802
[TBL] [Abstract][Full Text] [Related]
26. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
Mosqueda-Gómez JL; Montaño-Loza A; Rolón AL; Cervantes C; Bobadilla-del-Valle JM; Silva-Sánchez J; Garza-Ramos U; Villasís-Keever A; Galindo-Fraga A; Palacios GM; Ponce-de-León A; Sifuentes-Osornio J
Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
[TBL] [Abstract][Full Text] [Related]
27. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
[TBL] [Abstract][Full Text] [Related]
28. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality.
Papadimitriou-Olivgeris M; Marangos M; Fligou F; Christofidou M; Sklavou C; Vamvakopoulou S; Anastassiou ED; Filos KS
Diagn Microbiol Infect Dis; 2013 Oct; 77(2):169-73. PubMed ID: 23886789
[TBL] [Abstract][Full Text] [Related]
29. Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae?
Pea F; Della Siega P; Cojutti P; Sartor A; Crapis M; Scarparo C; Bassetti M
Int J Antimicrob Agents; 2017 Feb; 49(2):255-258. PubMed ID: 28012683
[TBL] [Abstract][Full Text] [Related]
30. Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge.
Navarro-San Francisco C; Mora-Rillo M; Romero-Gómez MP; Moreno-Ramos F; Rico-Nieto A; Ruiz-Carrascoso G; Gómez-Gil R; Arribas-López JR; Mingorance J; Paño-Pardo JR
Clin Microbiol Infect; 2013 Feb; 19(2):E72-9. PubMed ID: 23231088
[TBL] [Abstract][Full Text] [Related]
31. Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae.
Gonzalez-Padilla M; Torre-Cisneros J; Rivera-Espinar F; Pontes-Moreno A; López-Cerero L; Pascual A; Natera C; Rodríguez M; Salcedo I; Rodríguez-López F; Rivero A; Rodríguez-Baño J
J Antimicrob Chemother; 2015 Mar; 70(3):905-13. PubMed ID: 25344809
[TBL] [Abstract][Full Text] [Related]
32. Molecular epidemiology and risk factors for colistin- or tigecycline-resistant carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients during a 7-year period.
Papadimitriou-Olivgeris M; Bartzavali C; Spyropoulou A; Lambropoulou A; Sioulas N; Vamvakopoulou S; Karpetas G; Spiliopoulou I; Vrettos T; Anastassiou ED; Fligou F; Christofidou M; Marangos M
Diagn Microbiol Infect Dis; 2018 Nov; 92(3):235-240. PubMed ID: 30076041
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and mortality of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018-2022).
Boattini M; Bianco G; Bastos P; Comini S; Corcione S; Almeida A; Costa C; De Rosa FG; Cavallo R
Eur J Clin Microbiol Infect Dis; 2024 Jan; 43(1):155-166. PubMed ID: 37985552
[TBL] [Abstract][Full Text] [Related]
34. Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series.
Murri R; Fiori B; Spanu T; Mastrorosa I; Giovannenze F; Taccari F; Palazzolo C; Scoppettuolo G; Ventura G; Sanguinetti M; Cauda R; Fantoni M
Infection; 2017 Apr; 45(2):209-213. PubMed ID: 28185222
[TBL] [Abstract][Full Text] [Related]
35. Risk factors, outcomes and genotypes of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infection: a three-year retrospective study in a large tertiary hospital in Northern China.
Zheng SH; Cao SJ; Xu H; Feng D; Wan LP; Wang GJ; Xiao XG
Infect Dis (Lond); 2018 Jun; 50(6):443-451. PubMed ID: 29303020
[TBL] [Abstract][Full Text] [Related]
36. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
[TBL] [Abstract][Full Text] [Related]
37. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin.
Kontopoulou K; Protonotariou E; Vasilakos K; Kriti M; Koteli A; Antoniadou E; Sofianou D
J Hosp Infect; 2010 Sep; 76(1):70-3. PubMed ID: 20705205
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs.
Hagihara M; Crandon JL; Urban C; Nicolau DP
J Antimicrob Chemother; 2013 Jul; 68(7):1616-8. PubMed ID: 23475648
[TBL] [Abstract][Full Text] [Related]
39. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece).
Maltezou HC; Giakkoupi P; Maragos A; Bolikas M; Raftopoulos V; Papahatzaki H; Vrouhos G; Liakou V; Vatopoulos AC
J Infect; 2009 Mar; 58(3):213-9. PubMed ID: 19246099
[TBL] [Abstract][Full Text] [Related]
40. Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox?
Del Bono V; Giacobbe DR; Marchese A; Parisini A; Fucile C; Coppo E; Marini V; Arena A; Molin A; Martelli A; Gratarola A; Viscoli C; Pelosi P; Mattioli F
Virulence; 2017 Jan; 8(1):66-73. PubMed ID: 27430122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
